7 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Novo Nordisk A/S | 6 |
| Novo Nordick A/S | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19306057 | Untitled | Novo Nordisk A/S | HUDSON, AMY ROSE | 1636 | Final Rejection | |
| 18483540 | METHODS FOR THE TREATMENT OF NASH WITH ADVANCED FIBROSIS AND/OR CIRRHOSIS | Novo Nordisk A/S | ZAHORIK, AMANDA MARY | 1636 | Non-Final OA | Oct 10, 2023 |
| 18483541 | DOSAGE REGIMEN FOR THE TREATMENT OF NASH | Novo Nordisk A/S | CHONG, KIMBERLY | 1636 | Non-Final OA | Oct 10, 2023 |
| 18274826 | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM | Novo Nordisk A/S | SHEN, WU CHENG WINSTON | 1682 | Non-Final OA | Jul 28, 2023 |
| 18030230 | SELECTIVE DELIVERY OF OLIGONUCLEOTIDES TO GLIAL CELLS | Novo Nordisk A/S | YU, DELPHINUS DOU YI | 1636 | Non-Final OA | Apr 04, 2023 |
| 18019536 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC SYNDROME | Novo Nordick A/S | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Feb 03, 2023 |
| 18019531 | COMPOSITIONS AND METHODS FOR INHIBITING PLP1 EXPRESSION | Novo Nordisk A/S | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Feb 03, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial